Obesity is a common condition, impacting nearly 3 in 4 adults over the age of 20 in the United States. Research into obesity medications has increased significantly in recent years, resulting in novel weight-management drugs that are continuing to drive interest and demand. However, although obesity disproportionately impacts people of color, many of these studies are still made up of predominantly white individuals, creating a gap in knowledge about the effectiveness of these medications.
In this webinar, Antidote’s Principal Clinical Strategist, Dr. Rich Towne, discusses strategies for more diverse recruitment alongside Fil Guipoco, National Director of Community Impact and Strategic Alliances at Beyond Type 1.
Their conversation features:
- Insights for how sponsors can prioritize diversity in their recruiting
- What barriers to participation must be addressed
- How comorbidities can play a role in recruitment
Access this on-demand webinar!
